Skip to main content

02.04.2025 | case report

Diffuse large B-cell lymphoma of the right upper extremity misdiagnosed as soft tissue infection

Case report

verfasst von: Lipeng Cao, Danbo Cao

Erschienen in: memo - Magazine of European Medical Oncology

Einloggen, um Zugang zu erhalten

Summary

Diffuse large B‑cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma (NHL). It can originate in both lymph nodes and extranodal sites. Primary skin or soft tissue involvement of DLBCL is extremely rare and lacks specific clinical symptoms, making early diagnosis difficult. We report the case of a 48-year-old woman who initially presented with fever, redness, swelling, and pain in the right upper extremity without a palpable mass. A recent history of trauma led us to initially diagnose soft tissue infection. However, when the soft tissue infection did not respond to antibiotics, a pathological diagnosis of DLBCL was made following surgical amputation. This case highlights the complexity of diagnosing primary DLBCL in unusual locations and highlights the importance of timely and accurate diagnosis. Clinicians must remain vigilant and consider primary DLBCL as a potential diagnosis, especially in unusual sites.
Literatur
1.
Zurück zum Zitat Wang SS. Epidemiology and etiology of diffuse large B‑cell lymphoma. seminhematol. 2023;60(5):255–66. Wang SS. Epidemiology and etiology of diffuse large B‑cell lymphoma. seminhematol. 2023;60(5):255–66.
2.
Zurück zum Zitat Kyaw AMM, Aye TT, Htun LL. Diffuse large B cell lymphoma with cutaneous and gastrointestinal involvement. Case Rep Gastrointest Med. 2022;2022:2687291.PubMedPubMedCentral Kyaw AMM, Aye TT, Htun LL. Diffuse large B cell lymphoma with cutaneous and gastrointestinal involvement. Case Rep Gastrointest Med. 2022;2022:2687291.PubMedPubMedCentral
3.
Zurück zum Zitat Castillo JJ, Winer ES, Olszewski AJ. Sites of extranodal involvement are prognostic in patients with diffuse large B‑cell lymphoma in the rituximab era: an analysis of the surveillance, epidemiology, and end results database. Am J Hematol. 2014;89:310–4.PubMed Castillo JJ, Winer ES, Olszewski AJ. Sites of extranodal involvement are prognostic in patients with diffuse large B‑cell lymphoma in the rituximab era: an analysis of the surveillance, epidemiology, and end results database. Am J Hematol. 2014;89:310–4.PubMed
4.
Zurück zum Zitat Lee JH, Yun J. Diffuse large B‑cell lymphoma misdiagnosed as a hematoma: case report. Medicina. 2023;59(10):1775.PubMedPubMedCentral Lee JH, Yun J. Diffuse large B‑cell lymphoma misdiagnosed as a hematoma: case report. Medicina. 2023;59(10):1775.PubMedPubMedCentral
5.
Zurück zum Zitat Møller MB, Pedersen NT, Christensen BE. Diffuse large B‑cell lymphoma: clinical implications of extranodal versus nodal presentation—a population-based study of 1575 cases. Br J Haematol. 2004;124:151–9.PubMed Møller MB, Pedersen NT, Christensen BE. Diffuse large B‑cell lymphoma: clinical implications of extranodal versus nodal presentation—a population-based study of 1575 cases. Br J Haematol. 2004;124:151–9.PubMed
6.
Zurück zum Zitat Li S, Young KH, Medeiros LJ. Diffuse large B‑cell lymphoma. Pathology. 2018;50:74–87.PubMed Li S, Young KH, Medeiros LJ. Diffuse large B‑cell lymphoma. Pathology. 2018;50:74–87.PubMed
8.
Zurück zum Zitat Lee CH, Jeon SY, Yhim HY, et al. Disseminated soft tissue diffuse large B‑cell lymphoma involving multiple abdominal wall muscles: a case report. World J Clin Cases. 2021;9(28):8557–62.PubMedPubMedCentral Lee CH, Jeon SY, Yhim HY, et al. Disseminated soft tissue diffuse large B‑cell lymphoma involving multiple abdominal wall muscles: a case report. World J Clin Cases. 2021;9(28):8557–62.PubMedPubMedCentral
10.
Zurück zum Zitat Barraclough A, Hawkes E, Sehn L, Smith S. Diffuse large B‑cell lymphoma. Hematol Oncol. 2023;42(6):e3202.PubMedPubMedCentral Barraclough A, Hawkes E, Sehn L, Smith S. Diffuse large B‑cell lymphoma. Hematol Oncol. 2023;42(6):e3202.PubMedPubMedCentral
Metadaten
Titel
Diffuse large B-cell lymphoma of the right upper extremity misdiagnosed as soft tissue infection
Case report
verfasst von
Lipeng Cao
Danbo Cao
Publikationsdatum
02.04.2025
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-025-01026-7